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The Market Matters: Reforming the U.S. Health Care
System
Vincent E. Kerr, M.D.*
Epidemic of Care: A Call for Safer, Better, and More Accountable Health Care.
By George C. Halvorson & George J. Isham. San Francisco: Jossey-Bass,
2003. Pp. 271.
Imagine a world where few can afford necessary and life-saving
treatments, where hospitals and physicians can no longer provide
uncompensated care, where government and employers can pay for only
the barest safety net, and where health care facilities are so understaffed
that they are dangerous. That world may be closer than you think.
This nightmare scenario is suggested by recent trends cited in Epidemic
of Care: A Call for Safer, Better, and More Accountable Health Care.1 This book,
written by George Halvorson and George Isham, is a wonderful primer on
why health care in this country is as flawed and as expensive as it is, and it
presents information about which everyone should be concerned.
Medicare recipients, retired workers, active workers, the poor, the
unemployed, and children are all adversely affected by the poor quality of
care too often provided by today's health care system. No economic class
will go untouched if the disturbing picture Epidemic of Care paints of the
future of health care becomes a reality. But, perhaps more importantly,
Epidemic of Care is also a call to action.
Epidemic of Care begins with an extensive review of the twin crises of
escalating cost and questionable quality facing the American health care
system. This overview describes not only the present situation, but also
forecasts the likely economic implications of the current trajectory of
American health care.2 Halvorson and Isham both identify the problems
and, toward the end of the book, forward a "national health strategy" with
* President, Care Solutions, Uniprise, a United Health Group Company.
1. See GEORGE C. HALVORSON & GEORGEJ. IsHAM, EPIDEMIC OF CARE: A CALL FOR SAFER,
BETTER, AND MORE AccouNTABLE HEALTH CARE (2003).
2. See id. at 3545.
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clear initiatives to streamline and improve the current system.' They admit
that certain problems, such as the nursing shortage in this country and the
anticipated shortfall of other health care professionals in the near future,
do not seem to have easy answers.4 But they do suggest proposals-seven
broad, national initiatives-that adequately address other, perhaps more
pandemic problems, including the poor quality of health care delivery
today and the apparent paradox in the medical community's over-
provision of care despite being in the midst of a resource shortage.
Specifically, Epidemic of Care insists that before change can come, the
problems detailed in the first half of the book-specifically, the problems
with the cost and quality of care-must be recognized on a national level.
Only that national recognition will produce the resolve necessary to pursue
the seven broad initiatives that the authors argue will cure the woes of the
current system. The last seven chapters provide an analysis of the
proposals: (1) provide safer care; (2) create savings accounts for health
care to improve market dynamics for buying and selling health care; (3)
improve prevention efforts; (4) prevent provider monopolies and
anticompetitive behaviors; (5) fund programs for the uninsured; (6)
continue to fund training, education, and research; and perhaps most
importantly, (7) create an "automated medical record that will give the
doctor and patient in the exam room all of the information needed to
provide best care efficiently and consistently."5 The authors persuasively
argue that this last initiative is a prerequisite for successful implementation
of the other six.
Certainly, adoption of these recommendations would do much to
improve the delivery of care. Unfortunately, their seven initiatives alone
will not fully address the problems the authors so elegantly point out in the
first half of Epidemic of Care. Because the authors have paid insufficient
attention to issues of feasibility and implementation and the importance of
the market place, their proposals will not end the irrational financial
incentives and the vast clinical gray zone (i.e., the ever expanding number
of treatment choices and the imprecision and variability of arriving at
correct diagnoses) that exist in much of medicine. The authors have
suggested an intriguing, but ultimately only partial cure for what ails the
American health care system. The missing ingredients in this prescription
are a more thoughtful consideration of how their proposals might be
implemented and a more robust use of the power of market forces to
3. Id. at 155.
4. Id. at 234-35.
5. Id. at 157.
IV:2 (2004)
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achieve that end.
I. THE AUTHORS' BACKGROUNDS
To fully appreciate the perspective that Halvorson and Isham advance
in Epidemic of Care, a brief understanding of their backgrounds is critical.
Their proposed solutions are based, in part, on their experiences
managing regional health plans with large, closely affiliated physician
practice groups and hospitals. Halvorson is the chairman and CEO of
Kaiser Permanente, the nation's largest integrated, non-profit health care
delivery system.6 As a fully-integrated provider, Kaiser Permanente offers
multi-specialty insurance, hospital, and pharmacy services to its members.
Prior to Kaiser, Halvorson worked in Minnesota at HealthPartners,7 where
George Isham still serves as chief health officer and medical director."
HealthPartners offers an integrated package of health coverage, insurance,
and services. 9 Both authors have been leaders in improving clinical
processes and measurement, in part through their adoption of electronic
tools and support processes for physicians.
The authors contend that the example of improvements cultivated in
tightly controlled physician organizations similar to the ones with which
they have experience has relevance in a larger, more fragmented system
(i.e., the U.S. health care system). This is possible, they believe, if
government funding can be expanded to support technological
improvements such as automated electronic medical records, additional
training and education, and more research. 0 However, neither author has
had the opportunity to apply these same solutions on a truly national scale
to an unorganized delivery system, which is what any solution must do if it
is to be applied to the entire U.S. health care system. Indeed, the financial
structure of systems like Kaiser Permanente and HealthPartners of
Minnesota provides incentives to rationalize, without necessarily rationing,
medical care." Such organized delivery systems, though imperfect, are
capable of fostering wide adoption of clinical practice standards rarely seen
6. Id. at xxix.
7. Id.
8. Id. at xxx.
9. Id.
10. Id. at 180, 235.
11. Rational care makes trade-offs and judgments about efficacy within the context of
evidence-based medicine, but still provides the highest quality care. For example, using an
expensive anti-inflammatory when aspirin might be equally safe and efficacious would not
be condoned in a rational system.
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in the broader physician population. A different solution, however, may be
required for widespread implementation across the nation's health care
system.
II. THE HEALTH CARE CRISIS
In making their case that there are serious problems ailing the current
health care system, the authors point to several facts that have already been
widely publicized. They note that health care expenditures have risen for
the past five years at an alarming pace that is several times the rate of
inflation. However, while health care expenditures consume an increasing
percentage of the gross domestic product (GDP), the care received is often
unsafe, highly variable, and frequently falls far short of known clinical
standards in a way that few other industries would tolerate. The authors
draw the link between poor quality and higher cost, but do not stop there.
They also examine the role of private insurance as a funding mechanism
for health care and as an arbiter of societal mandates, the role of market
forces in the cost equation, and the mistakes of managed care over the past
decade.
Indeed, cost is unquestionably a significant issue. Affordability and
access to health care perennially rank high among the concerns of
Americans in Kaiser Family Foundation annual surveys.12 The popular press
echoes this sentiment. Over the past three years, health care issues,
particularly cost, have been the topic of innumerable, often front page,
stories in the national press.13
This past year, the Medicare reform bill that included a Medicare
prescription drug benefit appeared to be one of the most closely watched
and hotly debated issues in Congress. 14 At the core of this issue was
affordability for the nation-who should receive the benefit and who
should not, what would be covered, what the true projected cost of
providing such a benefit would be, who should pay and how much, and
how pharmaceutical manufacturers would be affected if the government
12. KAISER FAMILY FOUND., HEALTH CARE PRIORITIES (JAN./FEB. 2004), AT
HTrP://WWW.KFF.ORG/HEALTHPOLLREPORT/CURRENTEDITION/CARE/INDEX.CFM (LAST VISITED
MAY 8, 2004).
13. See, e.g., Chad Terhune, Fast Growing Health Plan has a Catch, WALL ST.J., May 14,
2003, at Al; Milt Freudenheim, Employees Paying Bigger Share for Healthcare, N.Y. TIMES, Sept.
10, 2003, at Al.
14. For information on the Medicare Prescription Drug Improvement and
Modernization Act (MMA) of 2003, see http://www.cms.hhs.gov/medicarereform (last
visited May 8, 2004).
IV:2 (2004)
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entered the prescription business for Medicare recipients. In this way, the
Medicare reform bill debates were similar to previous national discussions
on health care: Cost played a central role in every argument. The General
Accounting Office (GAO) estimates that, if the current rate of increases in
health care spending continue and if certain other assumptions are met,
the growth in percent of GDP consumed by health care could materially
affect our nation's ability to borrow from other nations within ten years.
This impact on the United States's ability to borrow could, at worst,
precipitate a call for repayment of existing debt.' 5 If this scenario were to
play out, it could cause a national financial crisis. Indeed, one could argue
that were it not for cost, much of the discussion about quality would not
take place and many of the discussants, particularly purchasers, would not
be as engaged.
If cost is central to the debate, who or what are the culprits? In
Epidemic of Care, the authors suggest many of the possible causes of
spiraling costs: health plans, providers, purchasers, patients, and medical
technology firms. They rightfully identify the changing payment
mechanism-from traditional indemnity insurance to HMOs to a more
relaxed managed care-as an additional cause. 6 The loss of defined fee
schedules and a reversion to a more conventional fee-for-service model to
cover procedures and services fundamentally changed the contract with
the insured and altered the dialogue between patients and insurers.
During the economic boom of the late 1990s, consumers resisted the
restrictions of traditional HMOs, and employers, eager to retain employees
during a tight labor market, paid for broader access to providers. Because
profits were high, they could afford these increased costs. This led to a
relaxation of tight managed care controls, resulting in diminished control
by the health plans over processes and costs.7 Meanwhile, medical
malpractice claims escalated, spawning medical necessity determinations.
Medical necessity led to increasing denials of care, which led to consumer
backlash. The backlash created loose or no controls and further escalation
of costs.'
8
Halvorson and Isham tend to view these changes as unique to the
health care industry, but one could argue that they are more directly
linked to economic factors external to the health care system. Arguably,
15. U.S. Gen. Accounting Office, Health Care System Crisis: Growing Challenges Point to
Need for Fundamental Reform, http://www.gao.gov/cghome/healthcare (Jan. 13, 2004).
16. HALVORSON & ISHAM, supra note 1, at 117-26.
17. Id. at 142.
18. Id. at 134-36.
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almost all cost developments-the demand for plans to leverage volume to
get price discounts; the Balanced Budget Act, which is curiously not
mentioned in the book but appeared to be responsible for a huge shift in
hospital pricing dynamics; 9 and even the backlash against managed care-
were lagging indicators directly linked to the overall state of the economy.
In fact, there have been cyclical expansions and contractions in health care
expenditure increases for the past forty years, roughly related to economic
cycles. °
Yet even while recognizing that the health care system does not exist in
a vacuum, it is also important to recognize that some of these cost
developments do result from factors unique to the health care system.
Indeed, the authors draw the inevitable link between poor quality and cost.
Five years ago a firestorm was unleashed when the national press, in
headline stories,2' seized upon an as yet unreleased report by the Institute
of Medicine which declared that the health care received in America's
hospitals is fundamentally unsafe and cited avoidable medical errors in
hospitals as one of the leading causes of death in this country.22 The story is
echoed in reports of high profile medical error cases such as that of Jessica
Santillan, the young woman whose death was due to an error in matching
23blood types.
Safety in the health care system is a pervasive and sentinel quality issue,
and this concern extends beyond the hospital safety concerns cited in the
original IOM report to the omissions of care in the ambulatory care
setting. As Beth McGlynn and others have reported, these omissions occur
at an alarmingly high rate,24 and the consequences of these omissions are
many: additional procedures, suffering, and years of life lost. Six sigma, a
19. The Balanced Budget Act of 1997 contained provisions on payment to physicians.
See, e.g., Balanced Budget Act of 1997, Pub. L. No. 105-33, 111 Stat. 251, 298. Hospitals,
often with forty percent or more of their revenue coming from Medicare, saw revenues fall,
which created pricing pressure on the private insurance market.
20. See, e.g., CTRS. FOR MEDICARE & MEDICAID SERVS., AN OVERVIEW OF THE US
HEALTHCARE SYSTEM: Two DECADES OF CHANGE 1980-2000,
http://www.cms.hhs.gov/charts/healthcaresystem/all.asp (last modified Oct. 27, 2003).
21. See, e.g., Bob Davis &Julie Appleby, Medical Mistakes e Top Killer, USA TODAY, Nov.
30, 1999, at Al.
22. For a copy of the report, see INST. OF MED., To ERR Is HUMAN: BUILDING A SAFER
HEALTH SYSTEM (2000), http://www.nap.edu/openbook/0309068371/html.
23. See, e.g., Dan Vergano, Teen Has 2nd Chance After Mismatch Forces 2d Transplant, USA
TODAY, Feb. 21, 2003, at Al.
24. See Elizabeth A. McGlynn et al., The Quality of Healthcare Delivered to Adults in the
United States, 348 NEW ENG.J. MED. 2635 (2003).
IV:2 (2004)
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statistically driven approach to process control used by many
manufacturers, teaches us that defects or mistakes represent waste, and
waste is costly.25 Manufacturers focus on controlling process to reduce the
number of defects and thus the amount of waste in producing a higher
yield of reliable goods. Almost by definition, this results in a cost benefit as
long as the price of achieving process control is less than the cost of the
waste being eliminated.
Another major problem that the authors address is the threat that the
uninsured pose to the current system. As employers, particularly small
businesses, scale back or even cancel health benefits, the number of
uninsured will rise, and, as a voting bloc, they will wield significant political
power.b Additionally, this will cause an increase in the amount of
uncompensated care, the cost of which is currently being shouldered by
others who use the system, including employers, payers, and hospitals.
Ironically, on a percent of charges basis, the greatest burden is shouldered
by those who fully pay their own bills since they do not enjoy the discounts
of group purchasers.
Thus, Halvorson and Isham persuasively argue that there are serious
problems in the United States health care system as it currently operates.
Yet because Halvorson and Isham fail to fully appreciate how these
problems influence-and are influenced by-market forces, their solutions
are necessarily limited. While they offer the beginnings of needed reform,
their recommendations by themselves do not go far enough to cure what
ails the U.S. health care system.
III. EPIDEMIC'S RECOMMENDATIONS
Solving these problems will undoubtedly require a political solution.27
25. For additional information about six sigma, see http://www.6-sigma.com (last
visited May 8, 2004).
26. While the uninsured today may be less likely to vote or contribute to political
campaigns, it is reasonable to assume that if their number increases and their demographic
profile shifts, the issue of coverage may become politicized. For example, if more active,
white collar workers lose health benefits and pay for an increasing share of their health care
costs, or as retirees find their private or federal health benefits shrinking, they will be more
likely to voice their concerns. For further discussion, see HALVORSON & ISHAM, supra note 1,
at xx-xxvii.
27. The problem of the uninsured presents just one example. Employers have long
been too inactive in this arena, but a sizable group of employers, under the auspices of the
Human Resources Policy Association (HRPA), have identified this issue as their number
one concern and are seeking to tackle it through a collaborative process. For more
HeinOnline  -- 4 Yale J. Health Pol'y L. & Ethics 437 2004
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As they transition toward their discussion of solutions, Halvorson and
Isham are correct in dismissing a single payer national health care system
solution. Even with age and other demographic adjusters, the United
18States is an outlier on medical per capital expenses. Beside the vested
interests of many incumbent stakeholders, the costs of centrally funding
benefits for all Americans would likely prove prohibitive given current
expense levels. The ability to control costs would hinge on politically
painful decisions such as rationing care. The authors cite the lack of a
Medicare drug benefit as proof of the government's willingness to ration
care, but the recent passage of the Medicare drug bill may have altered
their views.2 The core of the Medicare drug debate centered around
funding, and the design of the final plan was largely crafted to make it
affordable and its passage possible. The Medicare drug bill is a study in the
political challenges a single payer system would face. Even Senator Hillary
Clinton now acknowledges the failures of the Clinton Administration
proposal and is instead proposing precisely what the authors suggest in
their seventh-and fundamental-initiative: the creation of an electronic
medical information infrastructure.30
Although Halvorson and Isham list their recommendation to provide
electronic medical records (EMR) and aids last, it is actually the most
important as it is the critical underpinning of their other six ideas.
Improving quality care, their first initiative, as well as ensuring productivity
and consistency in the health care system, will be aided by an automated
medical record tool that enables access to legible, organized, historical
health information at multiple points of care. Additionally, this tool, as
envisioned by the authors, will support evidence-based clinical decision
processes, provide reminders, and generate data on performance. This
data will make it possible to evaluate process, thus providing another
opportunity for improvement in the quality of care.3 '
information on the HRPA, see http://www.hrpolicy.org (last visited May 12, 2004).
28. For more information, see Org. for Econ. Co-operation & Dev., Health at a Glance
2003 - OECD Countries Struggle with Rising Demand for Health Spending, at
http://www.oecd.org/document/38/0,2340,en_2649_201185_16560422_1_1_11_,00.html
(last visited May 12, 2004).
29. HALVORSON & ISHAM, supra note 1, at 145.
30. Senator Clinton made this remark during her keynote address at the World Health
Congress in Washington, D.C. on January 25, 2004. For more information about the World
Health Congress, see http://www.worldcongress.com (last visited May 8, 2004). For a review
of her speech, see Erik Goldman, Online Claims Processing: Sen. Clinton Eyes EMRs as New Key
to Reform, OB/GYN NEWS, Apr. 1, 2004, at 26.
31. HALVORSON & ISHAM, supra note 1, at 27.
IV:2 (2004)
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While an effective EMR tool would be a welcome improvement if
available to the broader population, it still falls far short of the goal of
aiding the logical clinical decision-making process. Here, Epidemic of Care
does not recognize the relevance of market dynamics and making use of
those dynamics to ensure the implementation of a more robust use of
EMR. Indeed, a truly complete EMR tool will tap into narrative records
with their wealth of clinical data; of course, the problems presented by
varying nomenclature, as well as the sensitivity and accuracy of observed
findings during physical examinations, will need to be solved. Technology
is rapidly reaching a point where it can support these aims. However, these
tools are not currently widely adopted because there is no compelling
incentive for health care providers to create that system for the key
stakeholders-whether doctors, patients, hospital administrators, health
plans, or employers. Market adoption will depend on creating those
incentives and disincentives. Although the authors suggest that additional
training or government funding will provide a stimulus to invest in
change,32 there are other factors that are far more likely to create that
effect. In particular, a broad and consistent demand for performance
measurement, the sharing of comparative information, and differentiating
providers and systems based on performance through information,
movement of patients, or financial reward are all powerful market tools
purchasers and payers have barely begun to use.
While EMR is Halvorson and Isham's most important
recommendation, their other six recommendations are also worthy of brief
discussion. Halvorson and Isham's first is to improve safety. 3 Given that it
intuitively makes sense that improved quality will lower costs, it is
unsurprising that this is their first recommendation. While reducing the
number of harmful errors and the overuse of procedures would clearly
have this effect, Halverson and Isham fail to recognize that since the goal
of health care is better outcomes in total for the patient and her family,
better quality may mean higher expenditures in some cases. 34 A more
32. Id. at 239.
33. Id. at 156.
34. For example, a forty-five year old male at risk for a heart attack may reduce his risk
by using pharmaco-therapeutic agents and making lifestyle changes. Since his risk of an
acute event is not absolute, and the certainty of his fate cannot be determined in advance
on an individual basis, he may use the drugs for a lifetime for an event he may never have
had, eliminating any return on his investment. Ignoring the impact on mortality and
morbidity for a moment, even if he knew with certainty his ultimate fate, the cost of
medication and treatment could exceed the cost of treating the acute event and, in the end,
is not guaranteed to absolutely avoid it. Prevalence, length of use, cost, adherence to
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expensive procedure may be less invasive, mean less disfigurement, or offer
greater diagnostic certainty. Patients may define this as better quality, even
if the outcome is unchanged. The cost of lifetime medication to prevent a
fatal event in a population at risk may exceed the cost of caring for the
minority who would suffer an event. While some economists argue that
these improvements lead to increased longevity and productivity that
exceed the medical expense by a factor of three or more,35 this is a difficult
analysis to prove and requires many unknown assumptions.36 Additionally,
because the recipient of health benefits is often not the one who pays for
those benefits, conventional cost-benefit analyses no longer hold, and our
notions of supply and demand curves must account for a system with three
(and sometimes even more) stakeholders. Nothing in the cost/quality
equation is helpful in dealing with the added expense of new, highly
effective, but expensive technology. While the authors identify this as an
issue,37 they do not adequately address it in their recommendations.
Halvorson and Isham's second proposal to ameliorate the current38
crisis-turn the patient into a consumer -is also not fully grounded in
the dynamics of the market. They cite the proliferation of the Internet and
the high hit rate of medical information sites as proof that patients are
interested in being better informed and becoming actively engaged in
medical decision making on issues such as choice of health plans,
providers, and therapies. 39 This is likely true, but given the wealth of
information available, its adoption and use by consumers seems
underwhelming. ° Part of the problem may be that the historical lack of
indications for use, the predictive capability of screening measures, and the efficacy of an
intervention including its unintended consequences or adverse side effects all determine if
an intervention is in fact cost effective.
35. See, e.g., David M. Cutler, The Real Medicare Conundrum, Presentation to the
Medical Technology Leadership Forum (Feb. 2004), at
http://www.mlf.org/events/pdf/cutlerPresentation.pdf (last visited May 8, 2004).
36. For example, Cutler's analysis relies on a set of assumptions about death and
disability rates and potential earning power and an ideal application of therapeutic
interventions. If these assumptions were to change, so would the return on investment he
estimates.
37. HALVORSON & ISHAM, supra note 1, at 40.
38. Id. at 99.
39. For a discussion of the role of the Internet in medical care, see HALVORSON & ISHAM,
supra note 1, at 99-108.
40. Internet site visit rates or "hits" should not be taken as proof that consumers are
factoring what they read on those sites into their decision making in a substantive way. In
addition unless we track reasons for usage, we do not know the reasons they visit these sites:
IV:2 (2004)
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relevancy of consumer information about health care has stymied
adoption.
More importantly, consumer health care decisions are emotive as well
as cognitive; not all individuals approach decision making in the same way,
and under different circumstances the same individual may place different
weights on what they value. For example, what one is willing to do for a
terminally ill child may differ from what one would be willing to do for
oneself in the same condition. The difference in risk between one health
care choice versus another may seem small in the eyes of a consumer. But
in a heavily personalized transaction it may well be that people value trust
and the personal relationship highly. The argument for providing as much
relevant and timely information as is feasible to consumers is strong. Some
will use it and benefit from it; others will not, but will at least have had the
opportunity to do so. If the goal is to influence patient decision making, we
may need tools that go well beyond the cognitive in order to reach patients
and address their more fundamental needs. To not anticipate this is to be
disappointed by the results. The drug makers who are successful in their
direct advertising appeal to consumers do this well, albeit to improve sales,
as do the makers of soap, coffee, and many other consumer commodities.
The third initiative, improving population health, is addressed
through the development of local community prevention goals.4' Setting
prevention targets for health plans is a bold and laudable move especially
for primary prevention efforts. The authors should also recognize the need
for public accountability in this regard and the benefit of community-wide
actions. The authors cite the obesity epidemic as an opportunity for
prevention efforts,42 but do not fully incorporate the way we work and play,
the food choices most widely promoted, and the relevant community
resources and social factors, all of which are tied into the obesity problem.
In addition, the authors have omitted the few relevant examples where
market-based forces have changed individual behavior. Johnson and
Johnson pioneered research in providing individuals with financial and
43
other incentives to adopt healthier lifestyles with some reported success.
One of the more intriguing elements of the Bridges to Excellence program
We do not know if they use them to research personal questions, questions for family
members, or if they are simply looking for general information.
41. HALVORSON & ISHAM, supra note 1, at 199.
42. Id. at 195.
43. Ronald Ozminkowski et al., Long-term Impact ofJohnson &Johnson's Health & Wellness
Program on Health Care Utilization and Expenditures, J. OCCUPATIONAL & ENVTL. MED, Jan. 2002,
at 21.
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is a schedule of rewards, very much like frequent flyer points, which can be
earned for certain behaviors and then redeemed for tangible items. 44 Such
designs are still novel and their effectiveness is not yet proven, but they are
intriguing in the context of creating new benefit designs with market
incentives (beyond the goal of improved health) for the patient.
As the authors point out in their explanation of the fourth initiative,
consolidation was a predictable response to market forces. 45 As payers
became larger and began to demand deeper discounts, providers
responded through a series of mergers and acquisitions to protect their
slim margins. Unfortunately for Halvorson and Isham, it may be too late
for antitrust efforts to remedy the problem in many markets. The
government is partly culpable not only because of the judiciary's
unwillingness to enforce antitrust law," but also because of its role as a
purchaser who sets the price in the marketplace. In the future, the
government must behave responsibly and use its leverage to further
performance reporting and create performance-based rewards. For
example, CMS could provide direct payments to any providers that
improve outcomes in a pre-determined set of clinical performance
measures. Other purchasers then need to follow suit and push for
reporting at the facility and provider level.
As mentioned above, the issue of the uninsured-initiative five-is
incredibly complex, and Halvorson and Isham have proposed a piecemeal
approach that would alleviate, but not solve, the problem. 47 Their ideas are
based on the fact that all uninsured are not equal. In particular, the
chronically uninsured account for about half of the national number. To
prevent corporations from dropping or drastically reducing coverage for
some employees, Halvorson and Isham suggest a "pay or play" model that
would require all employers to make a contribution toward health
coverage for each employee. 48 However, this sort of mandated change is
likely to be vigorously resisted by small employers." Similarly, it may be
44. Bridges to Excellence (BTE) is an employer sponsored initiative which aims to
reward physicians and patients for adhering to a set of evidence-based clinical practices in
managing chronic conditions such as diabetes and cardiovascular disease. Rewards for
physicians are based on qualification under the NCQA/DPRP program. For more
information, see Bridges to Excellence, at
http://www.ncqa.org/Programs/bridgestoexcellence/index.htm (last visited May 8, 2004).
45. HALvORSON & ISHAM, supra note 1, at 81.
46. Id. at 80.
47. Id. at 219-21.
48. Id. at 229.
49. This opinion is based on the reasonable assumption that small employers are less
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politically untenable to publicly fund even a minimum set of benefits for
the working poor. Such an action removes much of the motivation from
the employers who currently fund such programs for low wage earners.
Vouchers which would capitalize on private markets for supplying
insurance or care and which would limit the financial liability of the
government might have more political traction. In today's political
climate, one that seems ill-suited to addressing the needs of the uninsured,
the system of utilizing and expanding community-based clinics is likely to
be the most practical, although limited in its impact given current resource
allocation' l However, the initiation of change in any of these policies will
require both broad purchaser support and organized lobbying by the
medical community. Unfortunately, there is no ready prescription for
getting this to happen. Hospitals will likely continue to watch their payer
mix and devise strategies to avoid being swallowed by the cost, and the
current system will continue providing care until it becomes untenable.
The sixth initiative is aimed primarily at reducing the impending
shortages in many health care fields and calls for government to fund
training. More importantly it calls for research and support for the "re-
engineering" of health care.'2 Most industries that embark on this kind of
change do so because there is a critical business imperative. 3 That does not
exist in health care-yet. The good news is that there is precedent for this
kind of government funding. Taxpayer dollars have been used, not always
prudently, to support key industries and maintain a technical advantage
both in defense and in health research. 4 Such a mechanism could be used
equipped to absorb additional costs relating to health care since many currently do not
offer or subsidize health insurance to their employees. For more information about small
business owners and health care coverage, see Kaiser Family Found., National Survey of Small
Businesses, at http://www.kff.org/insurance/20020402a-index.cfm (2002).
50. This statement is based on the historical lack of political action to support the
uninsured working poor and the current environment that exhibits reluctance to fund new
or additional entitlements for the poor.
51. Capitalizing on an existing structure of publicly funded clinics may prove more
practical, since new funding may not be required if these clinics have unused capacity or
could inexpensively be offered as an option to those meeting income requirements.
52. HALvORSON & ISHAM, supra note 1, at 233-40.
53. For example, U.S. automotive manufacturers responded to the competitive threat of
imported makes with higher levels of quality by changing quality control, design
engineering, and manufacturing processes and ultimately improving the quality and
reliability of American manufactured automobiles.
54. Examples include the National Institute of Health (NIH), the space program,
weapons development, the formation of the RAND corporation in the 1940s in response to
HeinOnline  -- 4 Yale J. Health Pol'y L. & Ethics 443 2004
14
Yale Journal of Health Policy, Law, and Ethics, Vol. 4 [2004], Iss. 2, Art. 14
https://digitalcommons.law.yale.edu/yjhple/vol4/iss2/14
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
here, but as a nation we seem divided over how to view our health care
delivery infrastructure. Is it a public resource or a private industry? The
recent bio-terrorist threats certainly exposed fault lines in our thinking
about public health resources. Will market forces provide adequate
incentives and coherent direction to produce meaningful change? We
know we need hospitals and physicians, like fire stations, to be available
and prepared to respond in a crisis; but unlike most fire stations, we have
not yet decided how to fund them or make them completely adequate to
the task. Most care processes have not been engineered for efficiency. As
hospitals nurse thin margins and competitive forces siphon off profitable
procedures, a new urgency and focus on process efficiency may evolve.
Another catalyst may be the growing demand for comparative efficiency
measures.5 The ultimate marriage of reliable effectiveness and efficiency
measures will provide a powerful vehicle for channeling patients and
rewards and creating a strong market incentive for improvement.
IV. CONCLUDING THOUGHTS
Not only does Epidemic of Care fail to incorporate the realities of market
dynamics in its proposed solutions, but it also fails to mention several
promising market-based efforts to promote better care. For example, the
Bridges to Excellence program sponsored by GE, Ford, UPS, Verizon, and
other large employers in concert with health plans such as Humana,
United Healthcare, and others focuses on improved diabetic care in three
markets and supports the adoption of automated clinical office tools to
improve care.56 It relies on the American Diabetes Association/National
Committee for Quality Assurance (ADA/NCQA) physician recognition
program to achieve better outcomes and uses both benefit design and
patient incentives to achieve results. In fact, the authors cite the
ADA/NCQA program favorably. 7 It is one of a handful of programs that
pays physicians in the form of an annual per patient bonus based on
clinical performance.
the need for technological superiority in war, and, more recently, the support of the airline
industry following 9/11.
55. Examples of this growing demand include employer initiatives such as the Leapfrog
Group, which plans to look at efficiency measures in addition to quality outcomes. For
more information, see The Leapfrog Group, at http://www.leapfroggroup.org (last visited
May 13, 2004)
56. See Bridges to Excellence, Overview, at
http://www.bridgestoexcellence.org/bte/bteoverview.htm (last visited May 13, 2004).
57. HALVORSON & ISHAM, supra note 1, at 22.
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In addition, there is a wealth of activity in the marketplace focused on
the broad provider community. The National Quality Forum created
under the Clinton Administration has worked to endorse valid quality and
safety measures for the industry. 8 Some large national plans, such as
United Healthcare, are adopting these measure sets and actively
encouraging their collection and dissemination. 9 CMS has been active in
piloting quality performance demonstration projects and voluntary
hospital measure collections and in paying for performance initiatives.60
Other efforts driven largely by national self-insured employers are
pushing for provider level quality and efficiency measures. One of the most
notable is the Leapfrog Group, a consortium of over 150 large employers
who banded together initially to promote hospital safety through public
reporting about three important "leaps." Responding to the Institute of
Medicine report, To Err Is Human, which attributed between 44,000 and
100,000 deaths in hospitals to avoidable medical errors, 61 the Leapfrog
Group adopted three initial "leaps" correlated with lower incidences of
avoidable medical errors. 2 They asked hospitals to report on intensivist
staffing and rounding in intensive care units, adoption of computerized
order entry to reduce the number of drug errors, and the number of a
select group of surgical procedures performed in each hospital annually.
Each leap is measurable, attainable, and capable of producing safety and
outcome improvements immediately. It is curious that the authors, who
must have been familiar with this national effort, chose not to explore this
market based initiative in their discussion of safety. It is arguable that many
of the quality initiatives that followed, such as the partnership on voluntary
reporting of hospital performance measures sponsored by CMS, JCAHO,
and the AMA may have been directly influenced by the pressure of
Leapfrog. 3
58. See Nat'l Quality Forum, About the National Quality Forum, at
http://www.qualityforum.org/about/home.htm (last visited May 13, 2004).
59. For general information on UnitedHealth Group, see
http://www.unitedhealthgroup.com/ (last visited May 22, 2004).
60. See, e.g., Ctrs. for Medicare & Medicaid Servs., Premier Hospital Quality Incentive
Demonstration, at http://www.cms.hhs.gov/researchers/demos/phqidemo.asp (last visited
May 13, 2004).
61. INST. OF MED., supra note 22, at 1.
62. See The Leapfrog Group, Fact Sheet, at
http://www.leapfroggroup.org/FactSheets/LFFactSheet.pdf (last visited May 13, 2004).
63. For more on the voluntary reporting of hospital performance measures sponsored
by CMS,JGAHO, and AMA, see Ctrs. for Medicare & Medicaid Servs., Hospital Quality
Initiative, at http://www.cms.hhs.gov/quality/hospital/ (last visited May 13, 2004).
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The results can be heartening. One integrated care system in Virginia
estimates that their new electronic intensive care unit will improve care
while generating nearly two million dollars in cost savings.64 The ultimate
impact of these efforts is yet to be measured in full, but would seem to be
significant as adoption spreads. It is against this background that the seven
recommendations for new initiatives should be weighed. Efforts to improve
quality and safety will benefit from provider level data, but comparative
data for plans will evolve from the HEDIS-like data of the past and will
begin to focus not on average performance, but on how many patients
receive the correct care and how efficiently this care is provided. Plans will
be held accountable for encouraging reporting on critical measures and
for supporting processes that improve care. It is as yet unclear how large a
role government funding will play in supporting these efforts, but cost will
be an issue, and the cost is likely to be born in part by purchasers. Agency
funding has begun enabling research to help this effort.
The authors have also omitted another common argument in
discussions about changing the current system of health care delivery.
According to economist Milton Friedman, today's system is an aberration
of market forces because it is structured around a tax code favoring
employers over individual purchasers of health insurance. 65 If individuals
could claim the same deductions for health insurance that corporations
currently do, a very different market would exist. Friedman may well be
right. Products that have not yet been offered, such as an evidence-based
benefit design that would pay differentially for highly effective treatments,
or share more of the cost of treatment based on the known potential
clinical benefit, have not yet been tried and could help shape the market.
For any solution to be successful, it will have to be feasible in today's
environment of a dispersed, fee-for-service marketplace with a fragmented
physician corps and an increasingly consolidated hospital and specialist
system. These are not trivial considerations. Given this, Halvorson and
Isham have achieved the goal of providing a clarion call for action and in
dismissing the notion that a single payer system is a tenable solution for
this nation's health care woes. The seven initiatives that they propose are
important and should be recognized as steps in the right direction. The
most glaring problem with Epidemic of Care, however, is that it fails to
64. Cinda Becker, Telemedicine System Helps Manage ICUs, MODERN HEALTHCARE, Sept. 4,
2000, at 62.
65. See, e.g., Milton Friedman, How To Cure Healthcare, THE PUBLIC INTEREST (2001),
http://www.thepublicinterest.com/archives/2001winter/article .html (last visited May 13,
2004).
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recognize something that is of critical importance in assessing the
feasibility and effectiveness of suggested reforms in the United States: The
market matters. Had they recognized that fact and modified their
recommendations accordingly, their call to action could have been much
more; indeed, it could have served as a roadmap to implementation and,
ultimately, to change.
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